Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Five peptides containing amino acid sequences from the type 1 poliovirus structural protein VP1 have been synthesized. Each of the peptides was found capable of priming the immune system of rabbits for a long-lasting, virus-neutralizing IgG antibody response following a single inoculation of intact virus. One peptide directly induced the production of neutralizing antibody.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the complete neutralization of EMCV-3 capsids with EMCV-1 antisera suggests it is not a novel serotype but rather is a divergent EMCV-1 variant.”
From Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak (2026) · cites this paper as [80]
Citations
Cites
Prediction of protein antigenic determinants from amino acid sequences.
Hopp, T. P., & Woods, K. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3824 · Cited by 3,705
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
Ey, P. L., Prowse, S. J., & Jenkin, C. R. (1978) · Immunochemistry · doi:10.1016/0161-5890(78)90070-6 · Cited by 2,685
Methods of Hormone Radioimmunoassay
(1978) · Elsevier eBooks · doi:10.1016/b978-0-123-79260-0.x5001-8 · Cited by 2,077
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,065
Primary structure, gene organization and polypeptide expression of poliovirus RNA
Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., van der Werf, S., et al. (1981) · Nature · doi:10.1038/291547a0 · Cited by 914
Self-citationBittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R. A., Rowlands, D. J., & Brown, F. (1982) · Nature · doi:10.1038/298030a0 · Cited by 820
Racaniello, V. R., & Baltimore, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4887 · Cited by 550
Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine
Kleid, D. G., Yansura, D., Small, B., Dowbenko, D., Moore, D. M., Grubman, M. J., McKercher, P. D., Morgan, D. O., Robertson, B. H., & Bachrach, H. L. (1981) · Science · doi:10.1126/science.6272395 · Cited by 498
Liu, F.-T., Zinnecker, M., Hamaoka, T., & Katz, D. H. (1979) · Biochemistry · doi:10.1021/bi00571a022 · Cited by 460
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.
Pfaff, E., Mussgay, M., Böhm, H. O., Schulz, G. E., & Schaller, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01262.x · Cited by 361
Research works printed but not linked: 7
- Icenogle, J., Shiwen, H., Duke, G., Rueckert, R. & Anderegg, J. Virology (in the press).
- Dernick, R. Devl biol. Stand. 47, 319–333 (1981).
- Blondel, B., Crainic, R. & Horodniceanu, F. C. r. hebd. Séanc. Acad. Sci., Paris 294, 91–94 (1982).
- Laporte, J., Grosclaude, J., Vantychem, J., Bernard, S. & Rouze, P. C. r. hebd. Séanc. Acad. Sci., Paris 276, 3399–3401 (1973).
- Van der Werf, S. et al. Proc. natn. acad. Sci. U.S.A. (in the press).
- Wimmer, E., Emini, E. A. & Jameson, B. A. Rev. infect. Dis. (in the press).
- Barany, G. & Merrifield, R. B. in The Peptides (eds Gross, E. & Meienhoffer, J.) 1–284 (Academic, New York, 1979).
Cited by
Items 201–235 of 235
Carriers and adjuvants for the development of synthetic vaccines
Audibert, F. (1986) · Annales de l Institut Pasteur Virologie · doi:10.1016/s0769-2617(86)80268-4 · Cited by 2
Beginnings of the development of synthetic peptides as viral vaccines
Melnick, J. L. (1986) · Annales de l Institut Pasteur Virologie · doi:10.1016/s0769-2617(86)80264-7 · Cited by 2
Peptide Priming of a Poliovirus Neutralizing Antibody Response
Wimmer, E., Emini, E. A., & Jameson, B. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s505 · Cited by 2
“Since submission of this manuscript, the studies described here have been extended [23, 24].”
Self-citationPeptides: Chemistry, Biology, and Pharmacology
Judd, A. K., & Schoolnik, G. K. (1990) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60344-0 · Cited by 3
Hogle, J. M., Chow, M., & Filman, D. J. (1986) · Springer eBooks · doi:10.1007/978-1-4612-4958-0_1 · Cited by 2
Designing and Using Site-Specific Antibodies to Synthetic Peptides
Schaffhausen, B. S. (1985) · Springer eBooks · doi:10.1007/978-1-4684-4964-8_21 · Cited by 2
The Development of New Poliovirus Vaccines Based on Molecular Cloning
Nomoto, A., Kohara, M., Kuge, S., Abe, S., Semler, B. L., Komatsu, T., Arita, M., & Itoh, H. (1988) · Springer eBooks · doi:10.1007/978-1-4757-9268-3_5 · Cited by 2
Vaccines - the Synthetic Antigen Approach
Rowlands, D. J. (1986) · Springer eBooks · doi:10.1007/978-3-642-70535-9_11 · Cited by 2
Adhikari, A., Feng, K. H., Shrestha, A., Rodriguez, C. E., Nolan, E. C., Pye, G. W., Gauger, P. C., Denagamage, T., Holmes, E. C., & Allison, A. B. (2026) · PLOS Pathogens · doi:10.1371/journal.ppat.1013861 · Cited by 1
“As serotype designation is defined by the inability to be completely neutralized by antibodies raised against another serotype [80], the complete neutralization of EMCV-3 capsids with EMCV-1 antisera suggests it is not a novel serotype but rather is a divergent EMCV-1 variant.”
A Sabin 1 poliovirus-based vaccine vector transfects Vero cells with high efficiency
Li, C., Han, W., Zhang, Y., & Wang, J. (2007) · Cytotechnology · doi:10.1007/s10616-007-9085-0 · Cited by 1
“Alternatively, one day after the transfection, the medium was replaced with fresh growth medium containing 1% agarose, and plaque assays were performed as described by Emini et al. (1983) to determine the transfection efficiencies of the various vector RNAs.”
Host Immune Responses to Enterovirus Infections
Tracy, S., Chapman, N. M., Rubocki, R. J., & Beck, M. A. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch8 · Cited by 1
Riveros‐Moreno, V., & Beesley, J. E. (1990) · Springer eBooks · doi:10.1007/978-94-009-0783-6_25 · Cited by 1
Hogle, J. M., Chow, M., & Filman, D. J. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5272-3_24 · Cited by 1
Immunity to poliovirus after infection and vaccination
Herremans, M. M. P. T. (1999) · Utrecht University Repository (Utrecht University) · Cited by 1
Murdin, A. D. (1986) · Surrey Research Insight Open Access (The University of Surrey) · Cited by 1
Muller, C. P., & Pütz, M. M. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0123 · Cited by 1
The Three-dimensional Structure of Surface Antigens from Animal Viruses
Wilson, I. A. (1986) · Springer eBooks · doi:10.1007/978-1-4612-4958-0_2 · Cited by 1
Human IgG1 Hinge-Fragment as a Core Structure for Immunogens
Moroder, L., Hübener, G., & Gemeiner, M. (1995) · Studies in natural products chemistry · doi:10.1016/s1572-5995(96)80042-1
Recombination and Point Mutations in Type G Rotavirus Strains: The Challenges of Vaccine Development
Salem, A. N. B., Rouis, Z., Buesa, J., & Aouni, M. (2012) · InTech eBooks · doi:10.5772/33629
Current trends in molecular virology and their implications for the control of equine viruses
Cullinane, A. (1989) · Equine Veterinary Education · doi:10.1111/j.2042-3292.1989.tb01348.x
Structural polypeptides and antigenicity of poliovirus.
Taniguchi, K., & Urasawa, S. (1985) · Uirusu · doi:10.2222/jsv.35.17
Werner, G., & McCray, J. W. (1989) · Springer eBooks · doi:10.1007/978-1-4899-0891-9_12
Vaccine Production by Recombinant DNA Technology
Kang, C. Y. (1989) · Elsevier eBooks · doi:10.1016/b978-0-08-034730-1.50009-0
Racaniello, V. R. (1992) · Elsevier eBooks · doi:10.1016/b978-0-7506-9265-6.50015-4 · Cited by 4
The application of molecular biology to the development of new vaccines against poliomyelitis
Almond, J. W. (1989) · Springer eBooks · doi:10.1007/978-94-009-1067-6_7
Chapter 4 Picornavirus infections
(1985) · Perspectives in medical virology · doi:10.1016/s0168-7069(08)70012-0
(1999) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(08)70454-6
(1988) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(08)70015-9
Kleine, A. H., Glatz, J. F. C., van Nieuwenhoven, F. A., Vallinga, M., Salden, M., Bosman, F. T., Boersma, W. J. A., Zegers, N. D., & Vusse, G. J. (1990) · Springer eBooks · doi:10.1007/978-1-4615-3936-0_6
(1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.2040-2040b.1994
Structure, Proteolytic Processing, and Neutralization Antigenic Sites of Poliovirus
Diamond, D. C., Hanecak, R., Semler, B. L., Jameson, B. A., Bonin, J., & Wimmer, E. (1984) · Springer eBooks · doi:10.1007/978-3-642-70065-1_18
Self-citationHTLV-III/LAV: The Role of Molecular Biology in Viral Detection and Prevention
Jameson, B. A., Modrow, S., Gürtler, L. G., Eberle, J., Gelderblom, H., Wernicke-Jameson, D., von der Helm, K., Deinhardt, F. W., & Wolf, H. J. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2329-7_3
Self-citationChandpa, H. H., Ruchika, Naskar, S., Saneja, A., & Meena, J. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104647
Viral Particles at Atomic Resolution
Rossmann, M. G., Arnold, E., Kamer, G., Kremer, M. J., Luo, M., Smith, T. J., Vriend, G., Rueckert, R. R., Mosser, A. G., Sherry, B., et al. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5350-8_2
Molecular Approaches to Vaccines
Bachrach, H. L. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5110-8_19
Metadata
- Authors
- Emini, E. A., Jameson, B. A., & Wimmer, E.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- State University of New York (US)
- ORCID
- Wimmer, Eckard
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5928
- Pages
- 699-703
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989110977
- Cited by
- 237
- References
- 33
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 28.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- poliovirus type 1, synthetic peptides, peptide immunization, immune priming, neutralizing antibodies, IgG antibody response, rabbit immunization
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antibodies, Viral, Antigen-Antibody Complex, Antigens, Viral, Enzyme-Linked Immunosorbent Assay, Peptides, Rabbits, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.